|Articles|May 30, 2017
Medpace Renews Partnership with SCRS
SCRS announced that Medpace has extended its commitment as a Global Impact Partner by two years.
Advertisement
SCRS announced that Medpace has extended its commitment as a Global Impact Partner by two years. Under this partnership, Medpace will continue to serve on the SCRS Global Impact Board and work with the SCRS Leadership Council on strategic initiatives.
Read the full release
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Patient Recruitment in Clinical Trials: Why the Industry's Longstanding Approach Is No Longer Fit for Purpose
2
Precision Oncology Trials Need to Reflect the Complexity of Cancer Biology
3
ACT Brief: Portfolio-Level Recruitment Strategy, Structural Change Through Systems Thinking, and Kidney Function Preservation in IgAN
4
ACT Brief: Local-First Communication Design, RBQM Financial Impact, and First Oral PCSK9 Inhibitor
5